Not sure about NSCLC - I don't see merck running a P3 as a single agent. Prostrate is much more likely...but the the completion date on the P2 isn't until Feb 2012 http://www.clinicaltrials.gov/ct2/show/NCT00777959?term=ariad&rank=20